Healthcare and Lifesciences
VedaCorp advises Advent International on its ₹3,150 crore investment in listed Yatharth Hospitals. The deal marks one of the largest primary capital infusions by a private equity firm into a multi-specialty hospital chain.
About
Advent Internationl
Advent International is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 17 offices across five continents, Advent oversees more than USD $109 billion in assets under management as of June 30, 2026, and has made 460 investments across 45 countries.
Advent has extensive healthcare investing experience globally, with more than 55 healthcare investments across 17 countries over the past 35+ years.
Background
Veda Corporate Advisors (“VedaCorp”) is pleased to announce that we acted as the financial advisor to Advent International on its proposed investment of ₹3,150 crore into Yatharth Hospitals (NSE: YATHARTH, BSE: 543950), one of North India’s fastest-growing listed healthcare providers. Upon completion of the transaction, Advent is expected to acquire a significant minority stake of 24.9% in Yatharth Hospitals.
Founded in 2008, Yatharth Hospitals has built one of North India’s leading healthcare networks, operating nine multi-speciality hospitals with ~2,800 beds and an overall announced capacity of ~3,250 beds. The Company has consistently expanded its footprint through a combination of organic and inorganic growth, while maintaining a strong focus on clinical excellence, patient outcomes, and operational performance.
The transaction highlights our ability to assist leading private equity investors in transactions with marquee Companies. This marks VedaCorp’s 69th transaction in the healthcare & life sciences space, reaffirming our leadership position.